Fluoxetine enhances the anticonvulsant effects of conventional antiepileptic drugs in maximal electroshock seizures in mice

Pharmacological Reports

Volumn 58, Issue 1, 2006, Pages 83-90

  Borowicz, Kinga K ^a   Stepień, Karolina ^a   Czuczwar, Stanisław J ^a,b  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

Author keywords

5 HT reuptake inhibition; Antidepressant; Antiepileptic drugs; Depression; Epilepsy; Fluoxetine

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; FLUOXETINE; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CONVULSION; DOSE RESPONSE; DRUG BRAIN LEVEL; DRUG DOSE REGIMEN; DRUG POTENTIATION; ELECTRIC SHOCK; LONG TERM MEMORY; MALE; MENTAL TASK; MOTOR PERFORMANCE; MOUSE; NONHUMAN; PASSIVE AVOIDANCE; SEIZURE; SEIZURE THRESHOLD; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TASK PERFORMANCE;

EID: 33646194599     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Boissier JR, Tardy J, Diverres JC: Une nouvelle methode simple pour explorer l'action tranquilisante: le test de la cheminee. Med Exp (Basel), 1960, 3, 81-84.
2. C receptors, shows a proconvulsant action in the electroconvulsive threshold test in mice. Pharmacol Rep, 2005, 57, 121-123.
3. Browning RA, Wood AV, Merrill MA, Dailey JW, Jobe PC: Enhancement of the anticonvulsant effect of fluoxetine following blockade of 5-HT 1A receptors. Eur J Pharmacol, 1997, 336, 1-6.
4. Cooper GL: The safety of fluoxetine - An update. Br J Psychiatry, 1988, 153, 77-86.
5. Dailey JW, Naritoku DK: Antidepressants and seizures: clinical anecdotes overshadow neuroscience. Biochem Pharmacol, 1996, 52, 1323-1329.
6. Dailey JW, Yan QS, Mishra PK, Burger RL, Jobe PC: Effects of fluoxetine on convulsions and on brain serotonin as detected by microanalysis in genetically epilepsyprone rats. J Pharmacol Exp Ther, 1992, 2, 533-540.
7. Droulers A, Bodak A, Oudjhani M, Lefevre des Noetters V, Bodak A: Decrease of valproic acid concentration in the blood when coprescribed with fluoxetine. J Clin Psychopharmacol, 1997, 17, 139-140.
8. Ebert U: Basic mechanism of psychotropic drugs. Epilepsia, 2002, 43, Suppl 2, 2-7.
9. Favale E, Rubino V, Mainardi P, Lunardi G, Albano C: Anticonvulsant effect of fluoxetine on humans. Neurology, 1995, 45, 1926-1927.
10. Gross R, Dannon P, Lepkifker E, Zohar J, Kotler M: Generalized seizures caused by fluoxetine overdose. Am J Emerg Med, 1998, 3, 328-330.
11. Hernandez EJ, Williams PA, Dudek FE: Efects of fluoxetine and TFMPP on spontaneous seizures in rats with pilocarpine-induced epilepsy. Epilepsia, 2002, 43, 1337-1345.
12. Jalil P: Drug-drug interaction in reverse: toxic reaction following the combined administration of fluoxetine and phenytoin: two case reports. J Clin Psychopharmacol, 1999, 19, 471-472.
13. + channels by fluoxetine (Prozac). Br J Pharmacol, 2003, 138, 1119-1128.
14. Leander JD: Fluoxetine, a selective serotonin-uptake inhibitor, enhances the anticonvulsant effects of phenytoin, carbamazepine, and ameltolide (LY201116). Epilepsia, 1992, 33, 573-576.
15. Lemberger L, Rowe H, Carmichael R, Crabtree R, Horng JS, Bymaster F, Wong D: Fluoxetine, a selective serotonin uptake inhibitor. Clin Pharmacol Ther, 1978, 4, 421-429.
16. Litchfield JT, Wilcoxon F: A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther, 1949, 96, 99-113.
17. Lucena MI, Blanco E, Corrales MA, Berthier ML: Interaction of fluoxetine and valproic acid. Am J Psychiatry, 1998, 4, 575.
18. Magyar J, Rusznak Z, Harasztosi C, Konvely A, Pacher P, Banyasz T, Csaba P et al.: Differential effects of fluoxetine enantiomers in mammalian neural and cardiac tissues. Int J Mol Med, 2003, 11, 53 5-542.
19. Mamiya K, Kojima K, Yukawa E, Higuchi S, Ieiri I, Ninomiya H, Tashiro N: Phenytoin intoxication induced by fluvoxamine. Ther Drug Monit, 2001, 23, 75-77.
20. Ojemann LM, Baugh-Bookman C, Dudley DL: Effect of psychotropic medications on seizure control in patients with epilepsy. Neurology, 1987, 37, 1525-1527.
21. Oke A, Adhiyaman V, Aziz K, Ross A: Dose-dependent seizure activity associated with fluoxetine therapy. QJM, 2001, 94, 113-115.
22. Pasini A, Tortorella A, Gale K: The anticonvulsant action of fluoxetine in substantia nigra is dependent upon endogenous serotonin. Brain Res, 1996, 724, 84-88.
23. Perez V, Gilaberte I, Faries D, Alvares E, Artigas F: Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment. Lancet, 1997, 349, 1594-1597.
24. Pericic D, Iazic J, Strac DS: Anticonvulsant effects of acute and repeated fluoxetine treatment in unstressed and stressed mice. Brain Res, 2005, 1033, 90-95.
25. Pisani F, Spina E, Oteri G: Antidepressant drugs and seizure susceptibility: from in vitro data to clinical practice. Epilepsia, 1999, 40, Suppl, 10, S48-S56.
26. Prendiville S, Gale K: Anticonvulsant effect of fluoxetine on focally evoked limbic motor seizures in rats. Epilepsia, 1993, 34, 381-384.
27. Raju SS, Noor AR, Gurthu S, Giriyappenavar CP, Acharya SB, Low HC, Quah SH: Effect of fluoxetine on maximal electroshock seizures in mice: acute vs chronic administration. Pharmacol Res, 1993, 6, 451-454.
28. Rosenstein AL, Nelson JC, Jacobs SC: Seizures associated with antidepressants. A review. J Clin Psychiatry, 1993, 54, 289-299.
29. Shad MU, Preskorn SH: Drug-drug interaction in reverse: possible loss of phenytoin efficacy as a result of fluoxetine discontinuation. J Clin Psychopharmacol, 1999, 19, 5, 471-472.
30. Spina E, Avenoso A, Pollicin AM, Caputi AP, Pisani F: Carbamazepine coadministration with fluoxetine or fluvoxamine. Ther Drug Monit, 1993, 15, 247-250.
31. Ugale RR, Mittal. N, Hirani Y, Choprie CT: Essentiality of central GABAergic neuroactive steroid allopregnanolone for anticonvulsant action of fluoxetine against pentylenetetrazole-induced seizures in mice. Brain Res, 2004, 1023, 102-111.
32. Uzbay T, Saglam E, Kayir H, Celik T, Beyazyurek M: Effects of fluoxetine on ethanol withdrawal syndrome in rats. J Psychiatry Res, 2004, 38, 445-450.
33. Venault P, Chapouthier G, De Carvalho LP, Simiand J, Morre M, Dodd RH, Rossier J: Benzodiazepines impair and beta-carbolines enhance performance in learning and memory task. Nature, 1986, 321, 864-866.
34. Wada Y, Nakamura M, Hasegawa H, Yamaguchi N: Effect of serotonin uptake inhibiting antidepressant on hippocampal kindled seizures in cats. Neurosci Res Commun, 1993, 2, 119-124.
35. Wernicke JF: The side effect profile and safety of fluoxetine. J Clin Psychiatry, 1985, 46, 59-67.